News | July 30, 2024
Pfizer Ltd. posts Q1 FY25 PAT at Rs. 150.71 Cr
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
International Day of Yoga 2026 event highlights preventive healthcare, wellness-focused lifestyles and the growing global acceptance of yoga
CDMO strengthens global quality framework through digital transformation, AI-enabled investigations, workforce development and continuous audit readiness
Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets
Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country
The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments
Partnership will provide funding, incubation, mentorship, and industry exposure for ventures in healthcare, pharmaceuticals, biotechnology, medical technology, and agriculture
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
